{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T19:39:55Z","timestamp":1787168395965,"version":"build-2736575974"},"reference-count":116,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neural Regen Res"],"published-print":{"date-parts":[[2023]]},"DOI":"10.4103\/1673-5374.343884","type":"journal-article","created":{"date-parts":[[2022,7,9]],"date-time":"2022-07-09T12:50:54Z","timestamp":1657371054000},"page":"94","source":"Crossref","is-referenced-by-count":16,"title":["Crosslink between mutations in mitochondrial genes and brain disorders: implications for mitochondrial-targeted therapeutic interventions"],"prefix":"10.4103","volume":"18","author":[{"given":"Jaspreet","family":"Kalra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/1673-5374.343884-1","doi-asserted-by":"crossref","unstructured":"Armstrong JS (2007) Mitochondrial medicine: pharmacological targeting of mitochondria in disease. Br J Pharmacol 151:1154-1165.","DOI":"10.1038\/sj.bjp.0707288"},{"key":"key-10.4103\/1673-5374.343884-2","doi-asserted-by":"crossref","unstructured":"Baloyannis SJ (2009) Dendritic pathology in Alzheimer\u2019s disease. J Neurol Sci 283:153-157.","DOI":"10.1016\/j.jns.2009.02.370"},{"key":"key-10.4103\/1673-5374.343884-3","doi-asserted-by":"crossref","unstructured":"Bhatti JS, Bhatti GK, Reddy PH (2017) Mitochondrial dysfunction and oxidative stress in metabolic disorders-A step towards mitochondria based therapeutic strategies. Biochim Biophys Acta Mol Basis Dis 1863:1066-1077.","DOI":"10.1016\/j.bbadis.2016.11.010"},{"key":"key-10.4103\/1673-5374.343884-4","doi-asserted-by":"crossref","unstructured":"Bian M, Liu J, Hong X, Yu M, Huang Y, Sheng Z, Fei J, Huang F (2012) Overexpression of parkin ameliorates dopaminergic neurodegeneration induced by 1- methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. PLoS One 7:e39953.","DOI":"10.1371\/journal.pone.0039953"},{"key":"key-10.4103\/1673-5374.343884-5","doi-asserted-by":"crossref","unstructured":"Biskup S, Moore DJ, Celsi F, Higashi S, West AB, Andrabi SA, Kurkinen K, Yu SW, Savitt JM, Waldvogel HJ, Faull RL, Emson PC, Torp R, Ottersen OP, Dawson TM, Dawson VL (2006) Localization of LRRK2 to membranous and vesicular structures in mammalian brain. Ann Neurol 60:557-569.","DOI":"10.1002\/ana.21019"},{"key":"key-10.4103\/1673-5374.343884-6","doi-asserted-by":"crossref","unstructured":"Bulst S, Holinski-Feder E, Payne B, Abicht A, Krause S, Lochm\u00fcller H, Chinnery PF, Walter MC, Horvath R (2012) In vitro supplementation with deoxynucleoside monophosphates rescues mitochondrial DNA depletion. Mol Genet Metab 107:95-103.","DOI":"10.1016\/j.ymgme.2012.04.022"},{"key":"key-10.4103\/1673-5374.343884-7","doi-asserted-by":"crossref","unstructured":"C\u00e1mara Y, Gonz\u00e1lez-Vioque E, Scarpelli M, Torres-Torronteras J, Caballero A, Hirano M, Mart\u00ed R (2014) Administration of deoxyribonucleosides or inhibition of their catabolism as a pharmacological approach for mitochondrial DNA depletion syndrome. Hum Mol Genet 23:2459-2467.","DOI":"10.1093\/hmg\/ddt641"},{"key":"key-10.4103\/1673-5374.343884-8","doi-asserted-by":"crossref","unstructured":"Cassidy-Stone A, Chipuk JE, Ingerman E, Song C, Yoo C, Kuwana T, Kurth MJ, Shaw JT, Hinshaw JE, Green DR, Nunnari J (2008) Chemical inhibition of the mitochondrial division dynamin reveals its role in Bax\/Bak-dependent mitochondrial outer membrane permeabilization. Dev Cell 14:193-204.","DOI":"10.1016\/j.devcel.2007.11.019"},{"key":"key-10.4103\/1673-5374.343884-9","doi-asserted-by":"crossref","unstructured":"Chan DC (2020) Mitochondrial dynamics and its involvement in disease. Ann Rev Pathol 15:235-259.","DOI":"10.1146\/annurev-pathmechdis-012419-032711"},{"key":"key-10.4103\/1673-5374.343884-10","doi-asserted-by":"crossref","unstructured":"Chatterjee N, Walker GC (2017) Mechanisms of DNA damage, repair, and mutagenesis. Environ Mol Mutagen 58:235-263.","DOI":"10.1002\/em.22087"},{"key":"key-10.4103\/1673-5374.343884-11","doi-asserted-by":"crossref","unstructured":"Chlystun M, Campanella M, Law AL, Duchen MR, Fatimathas L, Levine TP, Gerke V, Moss SE (2013) Regulation of mitochondrial morphogenesis by annexin A6. PLoS One 8:e53774.","DOI":"10.1371\/journal.pone.0053774"},{"key":"key-10.4103\/1673-5374.343884-12","doi-asserted-by":"crossref","unstructured":"Chong MS, Goh LK, Lim WS, Chan M, Tay L, Chen G, Feng L, Ng TP, Tan CH, Lee TS (2013) Gene expression profiling of peripheral blood leukocytes shows consistent longitudinal downregulation of TOMM40 and upregulation of KIR2DL5A, PLOD1, and SLC2A8 among fast progressors in early Alzheimer\u2019s disease. J Alzheimers Dis 34:399-405.","DOI":"10.3233\/JAD-121621"},{"key":"key-10.4103\/1673-5374.343884-13","doi-asserted-by":"crossref","unstructured":"Chowdhury AR, Zielonka J, Kalyanaraman B, Hartley RC, Murphy MP, Avadhani NG (2020) Mitochondria-targeted paraquat and metformin mediate ROS production to induce multiple pathways of retrograde signaling: A dose-dependent phenomenon. Redox Biol 36:101606.","DOI":"10.1016\/j.redox.2020.101606"},{"key":"key-10.4103\/1673-5374.343884-14","doi-asserted-by":"crossref","unstructured":"Comte C, Tonin Y, Heckel-Mager AM, Boucheham A, Smirnov A, Aur\u00e9 K, Lomb\u00e8s A, Martin RP, Entelis N, Tarassov I (2013) Mitochondrial targeting of recombinant RNAs modulates the level of a heteroplasmic mutation in human mitochondrial DNA associated with Kearns Sayre Syndrome. Nucleic Acids Res 41:418-433.","DOI":"10.1093\/nar\/gks965"},{"key":"key-10.4103\/1673-5374.343884-15","doi-asserted-by":"crossref","unstructured":"Csire G, Canabady-Rochelle L, Averlant-Petit MC, Selmeczi K, Stefan L (2020) Both metal-chelating and free radical-scavenging synthetic pentapeptides as efficient inhibitors of reactive oxygen species generation. Metallomics 12:1220-1229.","DOI":"10.1039\/d0mt00103a"},{"key":"key-10.4103\/1673-5374.343884-16","doi-asserted-by":"crossref","unstructured":"Cui L, Jeong H, Borovecki F, Parkhurst CN, Tanese N, Krainc D (2006) Transcriptional repression of PGC-1alpha by mutant huntingtin leads to mitochondrial dysfunction and neurodegeneration. Cell 127:59-69.","DOI":"10.1016\/j.cell.2006.09.015"},{"key":"key-10.4103\/1673-5374.343884-17","doi-asserted-by":"crossref","unstructured":"Dan Wei, Gao N, Li L, Zhu JX, Diao L, Huang J, Han QJ, Wang S, Xue H, Wang Q, Wu QF, Zhang X, Bao L (2018) \u03b1-Tubulin acetylation restricts axon over branching by dampening microtubule plus-end dynamics in neurons. Cereb Cortex 28:3332-3346.","DOI":"10.1093\/cercor\/bhx225"},{"key":"key-10.4103\/1673-5374.343884-18","doi-asserted-by":"crossref","unstructured":"Davidzon G, Greene P, Mancuso M, Klos KJ, Ahlskog JE, Hirano M, DiMauro S (2006) Early-onset familial parkinsonism due to POLG mutations. Ann Neurol 59:859-862.","DOI":"10.1002\/ana.20831"},{"key":"key-10.4103\/1673-5374.343884-19","doi-asserted-by":"crossref","unstructured":"Dompierre JP, Godin JD, Charrin BC, Cordeli\u00e8res FP, King SJ, Humbert S, Saudou F (2007) Histone deacetylase 6 inhibition compensates for the transport deficit in Huntington\u2019s disease by increasing tubulin acetylation. J Neurosci 27:3571-3583.","DOI":"10.1523\/JNEUROSCI.0037-07.2007"},{"key":"key-10.4103\/1673-5374.343884-20","doi-asserted-by":"crossref","unstructured":"Dumont M, Stack C, Elipenahli C, Jainuddin S, Gerges M, Starkova N, Calingasan NY, Yang L, Tampellini D, Starkov AA. Chan RB, Di Paolo G, Pujol A, Beal MF (2012) Bezafibrate administration improves behavioral deficits and tau pathology in P301S mice. Hum Mol Genetics 21:5091-5105.","DOI":"10.1093\/hmg\/dds355"},{"key":"key-10.4103\/1673-5374.343884-21","doi-asserted-by":"crossref","unstructured":"Eerola J, Luoma PT, Peuralinna T, Scholz S, Paisan-Ruiz C, Suomalainen A, Singleton AB, Tienari PJ (2010) POLG1 polyglutamine tract variants associated with Parkinson\u2019s disease. Neurosci Lett 477:1-5.","DOI":"10.1016\/j.neulet.2010.04.021"},{"key":"key-10.4103\/1673-5374.343884-22","doi-asserted-by":"crossref","unstructured":"El Idrissi A, Trenkner E (2004) Taurine as a modulator of excitatory and inhibitory neurotransmission. Neurochem Res 29:189-197.","DOI":"10.1023\/B:NERE.0000010448.17740.6e"},{"key":"key-10.4103\/1673-5374.343884-23","doi-asserted-by":"crossref","unstructured":"El Idrissi A (2008) Taurine increases mitochondrial buffering of calcium: role in neuroprotection. Amino Acids 34:321-328.","DOI":"10.1007\/s00726-006-0396-9"},{"key":"key-10.4103\/1673-5374.343884-24","doi-asserted-by":"crossref","unstructured":"Fang YQ, Mao F, Zhu MJ, Li XH (2019) Compound heterozygous mutations in PARK2 causing early-onset Parkinson disease: a case report. Medicine 98:e14228.","DOI":"10.1097\/MD.0000000000014228"},{"key":"key-10.4103\/1673-5374.343884-25","doi-asserted-by":"crossref","unstructured":"Ferencz B, Karlsson S, Kalpouzos G (2012) Promising genetic biomarkers of preclinical Alzheimer\u2019s disease: the influence of APOE and TOMM40 on brain integrity. Int J Alzheimers Dis 2012:421-452.","DOI":"10.1155\/2012\/421452"},{"key":"key-10.4103\/1673-5374.343884-26","doi-asserted-by":"crossref","unstructured":"Fichi G, Naef V, Barca A, Longo G, Fronte B, Verri T, Santorelli FM, Marchese M, Petruzzella V (2019) Fishing in the cell powerhouse: zebrafish as a tool for exploration of mitochondrial defects affecting the nervous system. Int J Mol Sci 20:2409.","DOI":"10.3390\/ijms20102409"},{"key":"key-10.4103\/1673-5374.343884-27","doi-asserted-by":"crossref","unstructured":"Gloeckner CJ, Kinkl N, Schumacher A, Braun RJ, O\u2019Neill E, Meitinger T, Kolch W, Prokisch H, Ueffing M (2006) The Parkinson disease causing LRRK2 mutation I2020T is associated with increased kinase activity. Hum Mol Genet 15:223-232.","DOI":"10.1093\/hmg\/ddi439"},{"key":"key-10.4103\/1673-5374.343884-28","doi-asserted-by":"crossref","unstructured":"Goedert M, Jakes R, Spillantini MG (2017) The synucleinopathies: twenty years on. J Parkinsons Dis 7(s1):51-69.","DOI":"10.3233\/JPD-179005"},{"key":"key-10.4103\/1673-5374.343884-29","doi-asserted-by":"crossref","unstructured":"Gon\u00e7alves FB, Morais VA (2021) PINK1: a bridge between mitochondria and Parkinson\u2019s disease. Life 11:371.","DOI":"10.3390\/life11050371"},{"key":"key-10.4103\/1673-5374.343884-30","doi-asserted-by":"crossref","unstructured":"Goto Y, Nonaka I, Horai S (1990) A mutation in the tRNA (Leu) (UUR) gene associated with the MELAS subgroup of mitochondrial encephalomyopathies. Nature 348:651-653.","DOI":"10.1038\/348651a0"},{"key":"key-10.4103\/1673-5374.343884-31","doi-asserted-by":"crossref","unstructured":"Govindarajan N, Rao P, Burkhardt S, Sananbenesi F, Schl\u00fcter OM, Bradke F, Lu J, Fischer A (2013) Reducing HDAC6 ameliorates cognitive deficits in a mouse model for Alzheimer\u2019s disease. EMBO Mol Med 5:52-63.","DOI":"10.1002\/emmm.201201923"},{"key":"key-10.4103\/1673-5374.343884-32","doi-asserted-by":"crossref","unstructured":"Guedes-Dias P, Oliveira JM (2013) Lysine deacetylases and mitochondrial dynamics in neurodegeneration. Biochim Biophys Acta 832:1345-1359.","DOI":"10.1016\/j.bbadis.2013.04.005"},{"key":"key-10.4103\/1673-5374.343884-33","doi-asserted-by":"crossref","unstructured":"Guo X, Sun X, Hu D, Wang YJ, Fujioka H, Vyas R, Chakrapani S, Joshi AU, Luo Y, Mochly-Rosen D, Qi X (2016) VCP recruitment to mitochondria causes mitophagy impairment and neurodegeneration in models of Huntington\u2019s disease. Nat Commun 7:12646.","DOI":"10.1038\/ncomms12646"},{"key":"key-10.4103\/1673-5374.343884-34","doi-asserted-by":"crossref","unstructured":"Hansson CA, Frykman S, Farmery MR, Tjernberg LO, Nilsberth C, Pursglove SE, Ito A, Winblad B, Cowburn RF, Thyberg J, Ankarcrona M (2004) Nicastrin, presenilin, APH-1, and PEN-2 form active gamma-secretase complexes in mitochondria. J Biol Chem 279:51654-51660.","DOI":"10.1074\/jbc.M404500200"},{"key":"key-10.4103\/1673-5374.343884-35","doi-asserted-by":"crossref","unstructured":"Hollenbeck PJ, Saxton WM (2005) The axonal transport of mitochondria. J Cell Sci 118:5411-5419.","DOI":"10.1242\/jcs.02745"},{"key":"key-10.4103\/1673-5374.343884-36","doi-asserted-by":"crossref","unstructured":"Homma K, Toda E, Osada H, Nagai N, Era T, Tsubota K, Okano H, Ozawa Y (2021) Taurine rescues mitochondria-related metabolic impairments in the patient-derived induced pluripotent stem cells and epithelial-mesenchymal transition in the retinal pigment epithelium. Redox Biol 41:101921.","DOI":"10.1016\/j.redox.2021.101921"},{"key":"key-10.4103\/1673-5374.343884-37","unstructured":"Hou Y, Zhao XT, Xie ZY, Yuan Y, Wang ZX (2020) J Peking Univ Health Sci 52:851-855."},{"key":"key-10.4103\/1673-5374.343884-38","doi-asserted-by":"crossref","unstructured":"Hudson G, Schaefer AM, Taylor RW, Tiangyou W, Gibson A, Venables G, Griffiths P, Burn DJ, Turnbull DM, Chinnery PF (2007) Mutation of the linker region of the polymerase gamma-1 (POLG1) gene associated with progressive external ophthalmoplegia and Parkinsonism. Arch Neurol 64:553-557.","DOI":"10.1001\/archneur.64.4.553"},{"key":"key-10.4103\/1673-5374.343884-39","doi-asserted-by":"crossref","unstructured":"Inagaki R, Tagawa K, Qi ML, Enokido Y, Ito H, Tamura T, Shimizu S, Oyanagi K, Arai N, Kanazawa I, Wanker EE, Okazawa H (2008) Omi\/HtrA2 is relevant to the selective vulnerability of striatal neurons in Huntington\u2019s disease. Eur J Neurosci 28:30-40.","DOI":"10.1111\/j.1460-9568.2008.06323.x"},{"key":"key-10.4103\/1673-5374.343884-40","doi-asserted-by":"crossref","unstructured":"Jong CJ, Azuma J, Schaffer S (2012) Mechanism underlying the antioxidant activity of taurine: Prevention of mitochondrial oxidant production. Amino Acids 42:2223-2232.","DOI":"10.1007\/s00726-011-0962-7"},{"key":"key-10.4103\/1673-5374.343884-41","doi-asserted-by":"crossref","unstructured":"Kaarniranta K, Pawlowska E, Szczepanska J, Jablkowska A, Blasiak J (2019) Role of mitochondrial DNA damage in ROS-mediated pathogenesis of age-related macular degeneration (AMD). Int J Mol Sci 20:2374.","DOI":"10.3390\/ijms20102374"},{"key":"key-10.4103\/1673-5374.343884-42","doi-asserted-by":"crossref","unstructured":"Kausar S, Wang F, Cui H (2018) The role of mitochondria in reactive oxygen species generation and its implications for neurodegenerative diseases. Cells 7:274.","DOI":"10.3390\/cells7120274"},{"key":"key-10.4103\/1673-5374.343884-43","doi-asserted-by":"crossref","unstructured":"Kazak L, Reyes A, Holt IJ (2012) Minimizing the damage: repair pathways keep mitochondrial DNA intact. Nat Rev Mol Cell Biol 13:659-671.","DOI":"10.1038\/nrm3439"},{"key":"key-10.4103\/1673-5374.343884-44","doi-asserted-by":"crossref","unstructured":"Kessler C, Atasu B, Hanagasi H, Sim\u00f3n-S\u00e1nchez J, Hauser A, K Pak, M Bilgic, B Erginel-Unaltuna N, Gurvit H, Gasser T, Lohmann E (2018) Role of LRRK2 and SNCA in autosomal dominant Parkinson\u2019s disease in Turkey. Parkinsonism Relat Disord 48:34-39.","DOI":"10.1016\/j.parkreldis.2017.12.007"},{"key":"key-10.4103\/1673-5374.343884-45","doi-asserted-by":"crossref","unstructured":"Kim H, Lee JY, Park K J, Kim WH, Roh GS (2016) A mitochondrial division inhibitor, Mdivi-1, inhibits mitochondrial fragmentation and attenuates kainic acid-induced hippocampal cell death. BMC Neurosci 17:33.","DOI":"10.1186\/s12868-016-0270-y"},{"key":"key-10.4103\/1673-5374.343884-46","doi-asserted-by":"crossref","unstructured":"Kotrys AV, Szczesny RJ (2019) Mitochondrial gene expression and beyond-novel aspects of cellular physiology. Cells 9:17.","DOI":"10.3390\/cells9010017"},{"key":"key-10.4103\/1673-5374.343884-47","doi-asserted-by":"crossref","unstructured":"Kouli A, Torsney KM, Kuan WL (2018) Parkinson\u2019s disease: etiology, neuropathology, and pathogenesis. In: Parkinson\u2019s disease: pathogenesis and clinical aspects (Stoker TB, Greenland JC, eds) [Internet]. Brisbane:Codon Publications.","DOI":"10.15586\/codonpublications.parkinsonsdisease.2018.ch1"},{"key":"key-10.4103\/1673-5374.343884-48","doi-asserted-by":"crossref","unstructured":"Kr\u00fcger R, Kuhn W, M\u00fcller T, Woitalla D, Graeber M, K\u00f6sel S, Przuntek H, Epplen JT, Sch\u00f6ls L, Riess O (1998) Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson\u2019s disease. Nat Genet 18:106-108.","DOI":"10.1038\/ng0298-106"},{"key":"key-10.4103\/1673-5374.343884-49","doi-asserted-by":"crossref","unstructured":"Lee TS, Goh L, Chong MS, Chua SM, Chen GB, Feng L, Lim WS, Chan M, Ng TP, Krishnan KR (2012) Downregulation of TOMM40 expression in the blood of Alzheimer disease subjects compared with matched controls. J Psychiatr Res 46:828-830.","DOI":"10.1016\/j.jpsychires.2012.03.006"},{"key":"key-10.4103\/1673-5374.343884-50","doi-asserted-by":"crossref","unstructured":"Leit\u00e3o-Rocha A, Guedes-Dias P, Pinho BR, Oliveira JM (2015) Trends in mitochondrial therapeutics for neurological disease. Cur Med Chemistry 22:2458-2467.","DOI":"10.2174\/0929867322666150209160317"},{"key":"key-10.4103\/1673-5374.343884-51","doi-asserted-by":"crossref","unstructured":"Levy SL, Burnham WM, Bishai A, Hwang PA (1992) The anticonvulsant effects of vitamin E: a further evaluation. Can J Neurol Sci 19:201-203.","DOI":"10.1017\/S0317167100042268"},{"key":"key-10.4103\/1673-5374.343884-52","doi-asserted-by":"crossref","unstructured":"Li JX, Pang YZ, Tang CS, Li ZQ (2004) Protective effect of taurine on hypochlorous acid toxicity to nuclear nucleoside triphosphatase in isolated nuclei from rat liver. World J Gastroenterol 10:694-698.","DOI":"10.3748\/wjg.v10.i5.694"},{"key":"key-10.4103\/1673-5374.343884-53","doi-asserted-by":"crossref","unstructured":"Lin J, Handschin C, Spiegelman BM (2005) Metabolic control through the PGC-1 family of transcription coactivators. Cell Metab 2005 1:361-370.","DOI":"10.1016\/j.cmet.2005.05.004"},{"key":"key-10.4103\/1673-5374.343884-54","doi-asserted-by":"crossref","unstructured":"Lin MT, Beal MF (2006) Mitochondrial dysfunction and oxidative stress in neurodegenerative diseases. Nature 443:787-795.","DOI":"10.1038\/nature05292"},{"key":"key-10.4103\/1673-5374.343884-55","doi-asserted-by":"crossref","unstructured":"Linnertz C, Saunders AM, Lutz MW, Crenshaw DM, Grossman I, Burns DK, Whitfield KE, Hauser MA, McCarthy JJ, Ulmer M, Allingham R, Welsh-Bohmer KA, Roses AD, Chiba-Falek O (2012) Characterization of the poly-T variant in the TOMM40 gene in diverse populations. PLoS One 7:e30994.","DOI":"10.1371\/journal.pone.0030994"},{"key":"key-10.4103\/1673-5374.343884-56","doi-asserted-by":"crossref","unstructured":"Luoma PT, Eerola, J, Ahola S, Hakonen AH, Hellstr\u00f6m O, Kivist\u00f6 KT, Tienari PJ, Suomalainen A (2007) Mitochondrial DNA polymerase gamma variants in idiopathic sporadic Parkinson disease. Neurology 69:1152-1159.","DOI":"10.1212\/01.wnl.0000276955.23735.eb"},{"key":"key-10.4103\/1673-5374.343884-57","doi-asserted-by":"crossref","unstructured":"Lutz MW, Crenshaw DG, Saunders AM, Roses AD (2010) Genetic variation at a single locus and age of onset for Alzheimer\u2019s disease. Alzheimers Dement 6:125-131.","DOI":"10.1016\/j.jalz.2010.01.011"},{"key":"key-10.4103\/1673-5374.343884-58","doi-asserted-by":"crossref","unstructured":"Macia E, Ehrlich M, Massol R, Boucrot E, Brunner C, Kirchhausen T (2006) Dynasore, a cell-permeable inhibitor of dynamin. Dev Cell 10:839-850.","DOI":"10.1016\/j.devcel.2006.04.002"},{"key":"key-10.4103\/1673-5374.343884-59","doi-asserted-by":"crossref","unstructured":"Martin LJ, Pan Y, Price AC, Sterling W, Copeland NG, Jenkins NA, Price DL, Lee MK (2006) Parkinson\u2019s disease alpha-synuclein transgenic mice develop neuronal mitochondrial degeneration and cell death. J Neurosci 26:41-50.","DOI":"10.1523\/JNEUROSCI.4308-05.2006"},{"key":"key-10.4103\/1673-5374.343884-60","doi-asserted-by":"crossref","unstructured":"Mehvari J, Motlagh FG, Najafi M, Ghazvini MR, Naeini AA, Zare M (2016) Effects of vitamin E on seizure frequency, electroencephalogram findings, and oxidative stress status of refractory epileptic patients. Adv Biomed Res 5:36.","DOI":"10.4103\/2277-9175.178780"},{"key":"key-10.4103\/1673-5374.343884-61","doi-asserted-by":"crossref","unstructured":"Mihoub M, Abdallah J, Richarme G (2017) Protein repair from glycation by glyoxals by the DJ-1 family maillard deglycases. Adv Exp Med Biol 1037:133-147.","DOI":"10.1007\/978-981-10-6583-5_9"},{"key":"key-10.4103\/1673-5374.343884-62","doi-asserted-by":"crossref","unstructured":"Misrani A, Tabassum S, Yang L (2021) Mitochondrial dysfunction and oxidative stress in Alzheimer\u2019s disease. Front Aging Neurosci 13:57.","DOI":"10.3389\/fnagi.2021.617588"},{"key":"key-10.4103\/1673-5374.343884-63","doi-asserted-by":"crossref","unstructured":"Montagna P, Gallassi R, Medori R, Govoni E, Zeviani M, Di Mauro S, Lugaresi E, Andermann F (1988) MELAS syndrome: characteristic migrainous and epileptic features and maternal transmission. Neurology 38:751-754.","DOI":"10.1212\/WNL.38.5.751"},{"key":"key-10.4103\/1673-5374.343884-64","doi-asserted-by":"crossref","unstructured":"Murphy MP, Smith RA (2000) Drug delivery to mitochondria: the key to mitochondrial medicine. Adv Drug Deliv Rev 41:235-250.","DOI":"10.1016\/S0169-409X(99)00069-1"},{"key":"key-10.4103\/1673-5374.343884-65","doi-asserted-by":"crossref","unstructured":"Neueder A, Landles C, Ghosh R, Howland D, Myers RH, Faull R, Tabrizi SJ, Bates GP (2017) The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington\u2019s disease patients. Sci Rep 7:1307.","DOI":"10.1038\/s41598-017-01510-z"},{"key":"key-10.4103\/1673-5374.343884-66","doi-asserted-by":"crossref","unstructured":"Nishino I, Spinazzola A, Hirano M (1999) Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder. Science 283:689-692.","DOI":"10.1126\/science.283.5402.689"},{"key":"key-10.4103\/1673-5374.343884-67","doi-asserted-by":"crossref","unstructured":"Noe N, Dillon L, Lellek V, Diaz F, Hida A, Moraes CT, Wenz T (2013) Bezafibrate improves mitochondrial function in the CNS of a mouse model of mitochondrial encephalopathy. Mitochondrion 13:417-426.","DOI":"10.1016\/j.mito.2012.12.003"},{"key":"key-10.4103\/1673-5374.343884-68","doi-asserted-by":"crossref","unstructured":"Norat P, Soldozy S, Sokolowski JD, Gorick CM, Kumar JS, Chae Y, Ya\u011fmurlu K, Prada F, Walker M, Levitt MR, Price RJ, Tvrdik P, Kalani M (2020) Mitochondrial dysfunction in neurological disorders: Exploring mitochondrial transplantation. NPJ Regen Med 5:22.","DOI":"10.1038\/s41536-020-00107-x"},{"key":"key-10.4103\/1673-5374.343884-69","doi-asserted-by":"crossref","unstructured":"Nunnari J, Suomalainen A (2012) Mitochondria: in sickness and in health. Cell 148:1145-1159.","DOI":"10.1016\/j.cell.2012.02.035"},{"key":"key-10.4103\/1673-5374.343884-70","doi-asserted-by":"crossref","unstructured":"Ohsawa Y, Hagiwara H, Nishimatsu S I, Hirakawa A, Kamimura N, Ohtsubo H, Fukai Y, Murakami T, Koga Y, Goto YI, Ohta S, Sunada Y, KN01 Study Group (2019) Taurine supplementation for prevention of stroke-like episodes in MELAS: a multicentre, open-label, 52-week phase III trial. J Neurol Neurosurg Psychiatry 90:529-536.","DOI":"10.1136\/jnnp-2018-317964"},{"key":"key-10.4103\/1673-5374.343884-71","doi-asserted-by":"crossref","unstructured":"Orsucci D, Caldarazzo Ienco E, Mancuso M, Siciliano G (2011) POLG1-related and other \u201cmitochondrial Parkinsonisms\u201d: an overview. J Mol Neurosci 44:17-24.","DOI":"10.1007\/s12031-010-9488-9"},{"key":"key-10.4103\/1673-5374.343884-72","doi-asserted-by":"crossref","unstructured":"Pintoa M, Moraesa CT (2014) Mitochondrial genome changes and neurodegenerative diseases. Biochim Biophys Acta 1842:1198-1207.","DOI":"10.1016\/j.bbadis.2013.11.012"},{"key":"key-10.4103\/1673-5374.343884-73","doi-asserted-by":"crossref","unstructured":"Polymeropoulos MH, Lavedan C, Leroy E, Ide SE, Dehejia A, Dutra A, Pike B, Root H, Rubenstein J, Boyer R, Stenroos ES, Chandrasekharappa S, Athanassiadou A, Papapetropoulos T, Johnson WG, Lazzarini AM, Duvoisin RC, Di Iorio G, Golbe LI, Nussbaum RL (1997) Mutation in the alpha-synuclein gene identified in families with Parkinson\u2019s disease. Science 276:2045-2047.","DOI":"10.1126\/science.276.5321.2045"},{"key":"key-10.4103\/1673-5374.343884-74","doi-asserted-by":"crossref","unstructured":"Poon HF, Frasier M, Shreve N, Calabrese V, Wolozin B, Butterfield DA (2005) Mitochondrial associated metabolic proteins are selectively oxidized in A30P alpha-synuclein transgenic mice--a model of familial Parkinson\u2019s disease. Neurobiol Dis 18:492-498.","DOI":"10.1016\/j.nbd.2004.12.009"},{"key":"key-10.4103\/1673-5374.343884-75","doi-asserted-by":"crossref","unstructured":"Puigserver P (2005) Tissue-specific regulation of metabolic pathways through the transcriptional coactivator PGC1-alpha. Int J Obes (Lond) 29:S5-9.","DOI":"10.1038\/sj.ijo.0802905"},{"key":"key-10.4103\/1673-5374.343884-76","doi-asserted-by":"crossref","unstructured":"Puspita L, Chung SY, Shim JW (2017) Oxidative stress and cellular pathologies in Parkinson\u2019s disease. Mol Brain 10:53.","DOI":"10.1186\/s13041-017-0340-9"},{"key":"key-10.4103\/1673-5374.343884-77","doi-asserted-by":"crossref","unstructured":"Qi X, Qvit N, Su YC, Mochly-Rosen D (2013) A novel Drp1 inhibitor diminishes aberrant mitochondrial fission and neurotoxicity. J Cell Sci 126:789-802.","DOI":"10.1242\/jcs.114439"},{"key":"key-10.4103\/1673-5374.343884-78","doi-asserted-by":"crossref","unstructured":"Quinn P, Moreira PI, Ambr\u00f3sio AF, Alves CH (2020) PINK1\/PARKIN signalling in neurodegeneration and neuroinflammation. Acta Neuropathol Commun 8:189.","DOI":"10.1186\/s40478-020-01062-w"},{"key":"key-10.4103\/1673-5374.343884-79","doi-asserted-by":"crossref","unstructured":"Raninga PV, Di Trapani G, Tonissen KF (2017) The multifaceted roles of DJ-1 as an antioxidant. Adv Exp Med Biol 1037:67-87.","DOI":"10.1007\/978-981-10-6583-5_6"},{"key":"key-10.4103\/1673-5374.343884-80","doi-asserted-by":"crossref","unstructured":"Repici M, Giorgini F (2019) DJ-1 in Parkinson\u2019s disease: clinical insights and therapeutic perspectives. J Clin Med 8:1377.","DOI":"10.3390\/jcm8091377"},{"key":"key-10.4103\/1673-5374.343884-81","doi-asserted-by":"crossref","unstructured":"Rose J, Brian C, Woods J, Pappa A, Panayiotidis MI, Powers R, Franco R (2017) Mitochondrial dysfunction in glial cells: implications for neuronal homeostasis and survival. Toxicology 391:109-115.","DOI":"10.1016\/j.tox.2017.06.011"},{"key":"key-10.4103\/1673-5374.343884-82","doi-asserted-by":"crossref","unstructured":"Roses AD, Lutz MW, Amrine-Madsen H, Saunders AM, Crenshaw DG, Sundseth SS, Huentelman MJ, Welsh-Bohmer KA, Reiman EM (2010) A TOMM40 variable-length polymorphism predicts the age of late-onset Alzheimer\u2019s disease. Pharmacogenomics J 10:375-384.","DOI":"10.1038\/tpj.2009.69"},{"key":"key-10.4103\/1673-5374.343884-83","doi-asserted-by":"crossref","unstructured":"Roses AD, Lutz MW, Crenshaw DG, Grossman I, Saunders AM, Gottschalk WK (2013) TOMM40 and APOE: requirements for replication studies of association with age of disease onset and enrichment of a clinical trial. Alzheimers Dement 9:132-136.","DOI":"10.1016\/j.jalz.2012.10.009"},{"key":"key-10.4103\/1673-5374.343884-84","doi-asserted-by":"crossref","unstructured":"Schapira AH (2011) Mitochondrial pathology in Parkinson\u2019s disease. Mt Sinai J Med New York 78:872-881.","DOI":"10.1002\/msj.20303"},{"key":"key-10.4103\/1673-5374.343884-85","doi-asserted-by":"crossref","unstructured":"Schulz KL, Eckert A, Rhein V, Mai S, Haase W, Reichert AS, Jendrach M, M\u00fcller WE, Leuner K (2012) A new link to mitochondrial impairment in tauopathies. Mol Neurobiol 46:205-216.","DOI":"10.1007\/s12035-012-8308-3"},{"key":"key-10.4103\/1673-5374.343884-86","doi-asserted-by":"crossref","unstructured":"Shetewy A, Shimada-Takaura K, Warner D, Jong CJ, Mehdi AB, Alexeyev M, Takahashi K, Schaffer SW (2016) Mitochondrial defects associated with beta-alanine toxicity: relevance to hyper-beta-alaninemia. Mol Cell Biochem 416:11-22.","DOI":"10.1007\/s11010-016-2688-z"},{"key":"key-10.4103\/1673-5374.343884-87","doi-asserted-by":"crossref","unstructured":"Shim JH, Yoon SH, Kim KH, Han JY, Ha JY, Hyun DH, Paek SH, Kang UJ, Zhuang X, Son JH (2011) The antioxidant Trolox helps recovery from the familial Parkinson\u2019s disease-specific mitochondrial deficits caused by PINK1- and DJ-1-deficiency in dopaminergic neuronal cells. Mitochondrion 11:707-715.","DOI":"10.1016\/j.mito.2011.05.013"},{"key":"key-10.4103\/1673-5374.343884-88","doi-asserted-by":"crossref","unstructured":"Sies H, Jones DP (2020) Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat Rev Mol Cell Biol 21:363-383.","DOI":"10.1038\/s41580-020-0230-3"},{"key":"key-10.4103\/1673-5374.343884-89","doi-asserted-by":"crossref","unstructured":"Singh S, Singh TG, Rehni AK (2020) An insight into molecular mechanisms and novel therapeutic approaches in epileptogenesis. CNS Neurol Disord Drug Targets 19:750-779.","DOI":"10.2174\/1871527319666200910153827"},{"key":"key-10.4103\/1673-5374.343884-90","doi-asserted-by":"crossref","unstructured":"Singleton AB, Farrer M, Johnson J, Singleton A, Hague S, Kachergus J, Hulihan M, Peuralinna T, Dutra A, Nussbaum R, Lincoln S, Crawley A, Hanson M, Maraganore D, Adler C, Cookson MR, Muenter M, Baptista M, Miller D, Blancato J, et al. (2003) alpha-Synuclein locus triplication causes Parkinson\u2019s disease. Science 302:841.","DOI":"10.1126\/science.1090278"},{"key":"key-10.4103\/1673-5374.343884-91","doi-asserted-by":"crossref","unstructured":"Smith PM, Lightowlers RN (2011) Altering the balance between healthy and mutated mitochondrial DNA. J Inherit Metab Dis 34:309-313.","DOI":"10.1007\/s10545-010-9122-6"},{"key":"key-10.4103\/1673-5374.343884-92","doi-asserted-by":"crossref","unstructured":"Song W, Chen J, Petrilli A, Liot G, Klinglmayr E, Zhou Y, Poquiz P, Tjong J, Pouladi MA, Hayden MR, Masliah E, Ellisman, Rouiller I, Schwarzenbacher R, Bossy B, Perkins G., Bossy-Wetzel E (2011) Mutant huntingtin binds the mitochondrial fission GTPase dynamin-related protein-1 and increases its enzymatic activity. Nat Med 17:377-382.","DOI":"10.1038\/nm.2313"},{"key":"key-10.4103\/1673-5374.343884-93","doi-asserted-by":"crossref","unstructured":"Steele SL, Prykhozhij SV, Berman JN (2014) Zebrafish as a model system for mitochondrial biology and diseases. Transl Res 163:79-98.","DOI":"10.1016\/j.trsl.2013.08.008"},{"key":"key-10.4103\/1673-5374.343884-94","doi-asserted-by":"crossref","unstructured":"Stiles AR, Simon MT, Stover A, Eftekharian S, Khanlou N, Wang HL, Magaki S, Lee H, Partynski K, Dorrani N, Chang R, Martinez-Agosto JA, Abdenur JE (2016). Mutations in TFAM, encoding mitochondrial transcription factor A, cause neonatal liver failure associated with mtDNA depletion. Mol Genet Metab 119:91-99.","DOI":"10.1016\/j.ymgme.2016.07.001"},{"key":"key-10.4103\/1673-5374.343884-95","doi-asserted-by":"crossref","unstructured":"Strang KH, Golde TE, Giasson BI (2019) MAPT mutations, tauopathy, and mechanisms of neurodegeneration. Lab Invest 99:912-928.","DOI":"10.1038\/s41374-019-0197-x"},{"key":"key-10.4103\/1673-5374.343884-96","doi-asserted-by":"crossref","unstructured":"Su\u00e1rez-Rivero JM, Pastor-Maldonado CJ, Povea-Cabello S, \u00c1lvarez-C\u00f3rdoba M, Villal\u00f3n-Garc\u00eda I, Munuera-Cabeza M, Su\u00e1rez-Carrillo A, Talaver\u00f3n-Rey M, S\u00e1nchez-Alc\u00e1zar JA (2021) Coenzyme Q10Analogues: benefits and challenges for therapeutics. Antioxidants 10:236.","DOI":"10.3390\/antiox10020236"},{"key":"key-10.4103\/1673-5374.343884-97","doi-asserted-by":"crossref","unstructured":"Sun Y, Vashisht AA, Tchieu J, Wohlschlegel JA, Dreier L (2012) Voltage-dependent anion channels (VDACs) recruit Parkin to defective mitochondria to promote mitochondrial autophagy. J Biol Chem 287:40652-40660.","DOI":"10.1074\/jbc.M112.419721"},{"key":"key-10.4103\/1673-5374.343884-98","doi-asserted-by":"crossref","unstructured":"Suomalainen A, Battersby BJ (2018) Mitochondrial diseases: the contribution of organelle stress responses to pathology. Nat Rev Mol Cell Biol 19:77-92.","DOI":"10.1038\/nrm.2017.66"},{"key":"key-10.4103\/1673-5374.343884-99","doi-asserted-by":"crossref","unstructured":"Szeto HH (2006) Mitochondria-targeted peptide antioxidants: novel neuroprotective agents. AAPS J 8:E521-531.","DOI":"10.1208\/aapsj080362"},{"key":"key-10.4103\/1673-5374.343884-100","doi-asserted-by":"crossref","unstructured":"Takahashi-Niki K, Niki T, Iguchi-Ariga S, Ariga H (2017) Transcriptional regulation of DJ-1. Adv Exp Med Biol 1037:89-95.","DOI":"10.1007\/978-981-10-6583-5_7"},{"key":"key-10.4103\/1673-5374.343884-101","doi-asserted-by":"crossref","unstructured":"Tang WX, Wu WH, Qiu HY, Bo H, Huang SM (2013) Amelioration of rhabdomyolysis-induced renal mitochondrial injury and apoptosis through suppression of Drp-1 translocation. J Nephrol 26:1073-1082.","DOI":"10.5301\/jn.5000268"},{"key":"key-10.4103\/1673-5374.343884-102","doi-asserted-by":"crossref","unstructured":"Vezzani A, Balosso S, Ravizza T (2019) Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy. Nat Rev Neurol 15:459-472.","DOI":"10.1038\/s41582-019-0217-x"},{"key":"key-10.4103\/1673-5374.343884-103","doi-asserted-by":"crossref","unstructured":"Wanderoy S, Hees JT, Klesse R, Edlich F, Harbauer AB (2020) Kill one or kill the many: interplay between mitophagy and apoptosis. Biol Chem 402:73-88.","DOI":"10.1515\/hsz-2020-0231"},{"key":"key-10.4103\/1673-5374.343884-104","doi-asserted-by":"crossref","unstructured":"Wang JQ, Chen Q, Wang X, Wang QC, Wang Y, Cheng HP, Guo C, Sun Q, Chen Q, Tang TS (2013) Dysregulation of mitochondrial calcium signaling and superoxide flashes cause mitochondrial genomic DNA damage in Huntington disease. J Biol Chem 288:3070-3084.","DOI":"10.1074\/jbc.M112.407726"},{"key":"key-10.4103\/1673-5374.343884-105","doi-asserted-by":"crossref","unstructured":"Wang W, Zhao F, Ma X, Perry G, Zhu X (2020) Mitochondria dysfunction in the pathogenesis of Alzheimer\u2019s disease: recent advances. Mol Neurodegener 15:30.","DOI":"10.1186\/s13024-020-00376-6"},{"key":"key-10.4103\/1673-5374.343884-106","doi-asserted-by":"crossref","unstructured":"West AB, Moore DJ, Biskup S, Bugayenko A, Smith WW, Ross CA, Dawson VL, Dawson TM (2005) Parkinson\u2019s disease-associated mutations in leucine-rich repeat kinase 2 augment kinase activity. Proc Natl Acad Sci U S A 102:16842-16847.","DOI":"10.1073\/pnas.0507360102"},{"key":"key-10.4103\/1673-5374.343884-107","doi-asserted-by":"crossref","unstructured":"Westermann B (2012) Bioenergetic role of mitochondrial fusion and fission. Biochim Biophys Acta 1817:1833-1838.","DOI":"10.1016\/j.bbabio.2012.02.033"},{"key":"key-10.4103\/1673-5374.343884-108","doi-asserted-by":"crossref","unstructured":"Wilkins HM, Swerdlow RH (2017) Amyloid precursor protein processing and bioenergetics. Brain Res Bull 133:71-79.","DOI":"10.1016\/j.brainresbull.2016.08.009"},{"key":"key-10.4103\/1673-5374.343884-109","doi-asserted-by":"crossref","unstructured":"Xu K, Stringer JL (2008) Antioxidants and free radical scavengers do not consistently delay seizure onset in animal models of acute seizures. Epilepsy Behav 13:77-82.","DOI":"10.1016\/j.yebeh.2008.03.002"},{"key":"key-10.4103\/1673-5374.343884-110","doi-asserted-by":"crossref","unstructured":"Yan MH, Wang X, Zhu X (2013) Mitochondrial defects and oxidative stress in Alzheimer disease and Parkinson disease. Free Rad Biol Med 62:90-101.","DOI":"10.1016\/j.freeradbiomed.2012.11.014"},{"key":"key-10.4103\/1673-5374.343884-111","doi-asserted-by":"crossref","unstructured":"Yang L, Zhao K, Calingasan NY, Luo G, Szeto HH, Beal MF (2009) Mitochondria targeted peptides protect against 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine neurotoxicity. Antioxid Redox Signal 11:2095-2104.","DOI":"10.1089\/ars.2009.2445"},{"key":"key-10.4103\/1673-5374.343884-112","doi-asserted-by":"crossref","unstructured":"Young MJ, Copeland WC (2016) Human mitochondrial DNA replication machinery and disease. Curr Opin Genet Dev 38:52-62.","DOI":"10.1016\/j.gde.2016.03.005"},{"key":"key-10.4103\/1673-5374.343884-113","doi-asserted-by":"crossref","unstructured":"Zhang HT, Mi L, Wang T, Yuan L, Li XH, Dong LS, Zhao P, Fu JL, Yao BY, Zhou ZC (2016) PINK1\/Parkin-mediated mitophagy play a protective role in manganese induced apoptosis in SH-SY5Y cells. Toxicol In Vitro 34:212-219.","DOI":"10.1016\/j.tiv.2016.04.006"},{"key":"key-10.4103\/1673-5374.343884-114","doi-asserted-by":"crossref","unstructured":"Zhao K, Luo G, Giannelli S, Szeto HH (2005) Mitochondria-targeted peptide prevents mitochondrial depolarization and apoptosis induced by tert-butyl hydroperoxide in neuronal cell lines. Biochemical Pharmacol 70:1796-1806.","DOI":"10.1016\/j.bcp.2005.08.022"},{"key":"key-10.4103\/1673-5374.343884-115","unstructured":"Zhao Z, Fu A (2021) Mitochondrial therapy: a new strategy for treating mitochondrion-associated diseases. Chin J Biotechnol 37:1168-1177."},{"key":"key-10.4103\/1673-5374.343884-116","doi-asserted-by":"crossref","unstructured":"Zhu XH, Lu M, Chen W (2018) Quantitative imaging of brain energy metabolisms and neuroenergetics using in vivo X-nuclear 2H, 17O and 31P MRS at ultra-high field. J Magn Reson 292:155-170.","DOI":"10.1016\/j.jmr.2018.05.005"}],"container-title":["Neural Regeneration Research"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,19]],"date-time":"2026-08-19T18:35:51Z","timestamp":1787164551000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/1673-5374.343884"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":116,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023]]}},"alternative-id":["343884"],"URL":"https:\/\/doi.org\/10.4103\/1673-5374.343884","relation":{},"ISSN":["1673-5374"],"issn-type":[{"value":"1673-5374","type":"print"}],"subject":[],"published":{"date-parts":[[2023]]}}}